McKinsey and Company to pay huge settlement for being part of the opioid crisis
McKinsey and Company signed a deal with Purdue Pharma in 2013 to try to increase sales of Oxycontin. Federal prosecutors said the strategy was dangerous and made the opioid crisis worse.
